An efficient method for the rescue and analysis of functional HIV-1 env genes: Evidence for recombination in the vicinity of the tat/rev splice site

AIDS

Volumn 10, Issue 1, 1996, Pages 39-46

  Douglas, Nigel W ^a   Knight, Angus I ^a   Hayhurst, Andrew ^a   Barrett, Winsome Y ^a   Kevany, Michael J ^a   Daniels, Rod S ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Env genes; HIV 1; Phylogeny; Recombination; Sequence

Indexed keywords

CYSTEINE; GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; REV PROTEIN; RNA DIRECTED DNA POLYMERASE; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENVELOPE GENE; GENE ISOLATION; GENE SEQUENCE; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; RNA TRANSLATION;

EID: 0030067105     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199601000-00006     Document Type: Article

References (45)

1. Benn S, Rutledge R, Folks T, et al.: Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science 1985, 230:949-951.
2. Chameau P, Borman AM, Quillent C, et al.: Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 1994, 205:247-253.
3. Louwagie J, Janssens W, Mascola J, et al.: Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol 1995, 69:263-271.
4. Bour S, Geleziunas R, Wainberg MA: The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev 1995, 59:63-93.
5. Nixon DF, Broliden K, Ogg G, Broliden PA: Cellular and humoral antigenic epitopes in HIV and SIV. Immunology 1992, 76:515-534.
6. Javaherian K, Langlois AJ, McDanal C, et al.: Principal neutralizing domain of the human immunodeficiency virus type-1 envelope protein. Proc Natl Acad Sci USA 1989, 86:6768-6772.
7. Holmes EC, Zhang LQ, Simmonds P, Ludlam CA, Leigh-Brown AJ: Convergent and divergent sequence evolution in the envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci USA 1992, 89:4835-4839.
8. Bruce C, Clegg C, Featherstone A, et al.: Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda. AIDS Res Hum Retroviruses 1994, 10:1543-1550.
9. Myers G, Korber B, Wain-Hobson S, Jeang K-T, Henderson LE, Pavlakis GN (Eds): Human Retroviruses and AIDS. Los Alamos, New Mexico: Los Alamos National Laboratory; 1994.
10. Pantaleo G, Demarest JF, Vaccarezza M, et al.: Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission. Eur J Immunol 1995, 25:226-231.
11. Moore JP, Cao Y, Qing L, et al.: Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralisation by monoclonal antibodies to gp120, and their neutralisation is not predicted by studies with monomeric gp120. J Virol 1995, 69:101-109.
12. Moore JP, Trkola A, Korber B, et al.: A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B. J Virol 1995, 69:122-130.
13. Moore JP, Willey RL, Lewis GK, Robinson J, Sodroski J: Immunological evidence for interactions between the first, second and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. J Virol 1994, 68:6836-6847.
14. Daniels RS, Smith MH, Fisher AG: Molecular characterisation of biologically diverse envelope variants of human immunodeficiency virus type 1 derived from an individual. J Virol 1991, 65:5574-5578.
15. Gao F, Yue L, Stevenson C, et al.: Genetic variation of HIV type 1 in four World Health Organisation-sponsored vaccine evaluation sites; generation of functional envelope (glycoprotein 160) clones representative of subtypes A, B, C and E. AIDS Res Hum Retroviruses 1994, 10:1359-1368.
16. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory; 1982:269-295.
17. Nomenclature Committee of the International Union of Biochemistry: Nomenclature for incompletely specified bases in nucleic acid sequences. Eur J Biochem 1985, 150:1-5.
18. Moss B, Elroy-Stein O, Mizukami T, Alexander WA, Fuerst TR: New mammalian expression vectors. Nature 1990, 348:91-92.
19. Gleeson TJ, Staden R: An X windows and UNIX implementation of our sequence analysis package [letter]. Comput Appl Biosci 1991, 7:398.
20. Devereux J, Haeberli P, Smithies O: A comprehensive set of sequence-analysis programs for the Vax. Nucleic Acids Res 1984, 12:387-395.
21. Higgins DG, Sharp PM: CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene 1988, 73:237-244.
22. Felsenstein J: Phylogenies from molecular sequences: inference and reliability. Ann Rev Genet 1988, 22:521-565.
23. Smith SW, Overbeek R, Woese CR, Gilbert W, Gillevet PM: The genetic data environment an expandable GUI for multiple sequence analysis. Comput Appl Biosci 1994, 10:671-675.
24. Modrow S, Hahn BH, Shaw GM, Gallo RC, Wong-Staal F, Wolf H: Computer-assisted analysis of envelope protein sequences of 7 human immunodeficiency virus isolates - prediction of antigenic epitopes in conserved and variable regions. J Virol 1987, 61:570-578.
25. Olsen GJ, Matsuda H, Hagstrom R, Overbeek R: fastDNAml, a tool for construction of phylogenetic trees of DNA sequences using maximium likelihood. Comput Appl Biosci 1994, 10:41-48.
26. Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk HD, Garten W: Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 1992, 360:358-361.
27. Kennedy RC, Henkel RD, Pauletti D, et al.: Antisera to a synthetic peptide recognize the HTLV-III envelope protein. Science 1986, 231:1556-1559.
28. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ: Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 1990, 265:10373-10382.
29. Bosch ML, Andeweg AC, Schipper R, Kenter M: Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 surface glycoprotein through AAT triplet reiteration. J Virol 1994, 68:7566-7569.
30. Wu Z, Kayman SC, Honnen W, et al.: Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120; role of glycosylation in the correct folding of the V1/V2 domain. J Virol 1995, 69:2271-2278.
31. Wang W-K, Essex M, Lee T-H: The highly conserved aspartic acid residue between hypervariable regions 1 and 2 of human immunodeficiency virus type 1 gp120 is important for early stages of virus replication. J Virol 1995, 69:538-542.
32. Shioda T, Oka S, Ida S, et al.: A naturally occurring single basic amino acid substitution of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus. J Virol 1994, 68:7689-7696.
33. Gram GJ, Hemming A, Bolmstedt A, et al.: Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Arch Virol 1994, 139:253-261.
34. Shimizu H, Hasebe F, Tsuchie H, Morikawa S, Ushijima H, Kitamura T: Analysis of a human-immunodeficiency-virus type-1 isolate carrying a truncated transmembrane glycoprotein. Virology 1992, 189:534-546.
35. Zaides V, Yagello M, Veselovskaya T, et al.: Extensive C-terminal deletion in human immunodeficiency virus type 1 env glycoprotein arising after long-term culture of chronically infected cells. J Gen Virol 1994, 75:2963-2975.
36. Mulligan MJ, Yamshchikov GV, Ritter GD, et al.: Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human-immunodeficiency-virus type-2 in selected cell-types. J Virol 1992, 66:3971-3975.
37. Haffar OK, Nakamura GR, Berman PW: The carboxy terminus of human-immunodeficiency-virus type-1 gp160 limits its proteolytic processing and transport in transfected cell-lines. J Virol 1990, 64:3100-3103.
38. WHO Network for HIV Isolation and Characterization: HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites; genetic screening, sequence analysis and preliminary biological characterization of selected viral strains. AIDS Res Hum Retroviruses 1994, 10:1327-1343.
39. Klarmann GJ, Schauber CA, Preston BD: Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro. J Biol Chem 1993, 268:9793-9802.
40. Wu W, Blumberg BM, Fay PJ, Bambara RA: Strand transfer mediated by human immunodeficiency virus reverse transcriptase in vitro is promoted by pausing and results in misincorporation. J Biol Chem 1995, 270:325-332.
41. Robertson DL, Hahn BH, Sharp PM: Recombination in AIDS viruses. J Mol Evol 1995, 40:249-259.
42. Artenstein AW, VanCott TC, Mascola JR, et al.: Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J Infect Dis 1995, 171:805-810.
43. Diaz RS, Sabino EC, Mayer A, Mosley JW, Busch MP and the Transfusion Safety Study Group: Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. J Virol 1995, 69:3273-3281.
44. Zhu T, Wang N, Carr A, Wolinsky S, Ho DD: Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconverter. J Virol 1995, 69:1324-1327.
45. Leitner T, Escanilla D, Marquina S, et al.: Biological and molecular characterization of subtype D, G and A/D recombinant HIV-1 transmissions in Sweden. Virology 1995, 209:136-146.